Comprehensive Pan-cancer Analysis of CMPK2 as Biomarker and Prognostic Indicator for Immunotherapy.

Jingyuan LuoQianyue ZhangShutong WangLuojie ZhengJie LiuYuchen ZhangYingchen WangRanran WangZhigang XiaoZheng Li

Published in: Current cancer drug targets (2024)

Our analysis preliminarily describes the complex function of CMPK2 in cancer progression and immune microenvironment highlighting its potential as a diagnostic and therapeutic target for immunotherapy.

Keyphrases

papillary thyroid
squamous cell
stem cells
lymph node metastasis
squamous cell carcinoma